Advertisement
Advertisement
U.S. Markets close in 2 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.79-1.01 (-6.82%)
As of 01:05PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close14.80
Open14.83
Bid13.91 x 1000
Ask13.98 x 1000
Day's Range13.63 - 15.37
52 Week Range4.61 - 15.64
Volume549,891
Avg. Volume1,383,222
Market Cap663.157M
Beta (5Y Monthly)0.33
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis

    SOUTH SAN FRANCISCO, Calif., November 15, 2021--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today reported interim results from the Phase 2 portion of its MISSION clinical trial evaluating KZR-616, a first-in-class selective immunoproteasome inhibitor, in patients with active, proliferative lupus nephritis (LN).

  • Business Wire

    Kezar Life Sciences to Present at the Jefferies London Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., November 11, 2021--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available for on-demand viewing starting Thursday, November 18 at 3:00 a.m. EST.

  • Business Wire

    Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc.

    ALEXANDRIA, Va. & SOUTH SAN FRANCISCO, Calif., November 10, 2021--Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc.

Advertisement
Advertisement